Last updated: February 24, 2026
What is the scope of patent PL2819648?
Patent PL2819648 pertains to a pharmaceutical invention with a defined scope centered on a specific therapeutic application, formulation, or compound. Based on available data, the patent claims cover a novel composition, method of use, or process related to a drug candidate.
The patent's claims are directed toward protecting:
- A specific chemical entity or class of compounds.
- A particular formulation or delivery method.
- A method of treatment involving the compound.
- A manufacturing process.
The scope is intended to secure exclusive rights over these aspects within Poland's jurisdiction, preventing third parties from manufacturing, using, or selling the patented invention without authorization.
What are the key claims of patent PL2819648?
The patent document contains core claims and dependent claims. The core claims typically define the invention's broadest scope, with dependent claims narrowing the scope to particular embodiments or specific details.
Example of core claims:
| Claim Type |
Details |
| Composition |
A pharmaceutical composition comprising [active compound] in a specific concentration or combination. |
| Method |
A method for treating [disease] comprising administering [active compound] at a defined dosage and frequency. |
| Manufacturing process |
A process involving steps to synthesize or formulate the compound or composition. |
Claim characteristics:
- Broad claims may cover a class of compounds or methods.
- Narrow claims specify particular dosages, formulations, or treatment regimes.
- The claims aim to prevent competitors from developing similar drugs or methods for the same therapeutic target.
Limitation and scope:
- Claims are limited to the specific embodiments described in the patent.
- Functional claiming language may be used, such as "a method for treating [disease] by administering a compound that does [specific function]."
- The scope is confined geographically to Poland, but may influence broader markets if the patent is part of a global filing strategy.
What is the patent landscape surrounding PL2819648?
Related patents and filings
- Patent families and continuation applications suggest research continuity.
- Similar patents filed within European Patent Organization (EPO) regions, including neighboring markets.
- Patent landscapes reveal competing claims and the level of innovation in this therapeutic area.
Competitive landscape
- Multiple filings by the same assignee or competitors patenting similar compounds or methods.
- Overlapping claims which can lead to patent oppositions or litigations.
- Existing patents in related classes, notably compounds targeting [therapeutic area], impacting freedom-to-operate.
Patent classification and keywords
- Classified under Cooperative Patent Classification (CPC) codes relevant to pharmaceuticals, such as A61K (medical preparations).
- Keywords used in the patent filings include the active compound name, disease target, or formulation terms.
Patent filing trends in Poland
- Increase in pharmaceutical patent filings from 2010 to 2022 indicates active R&D.
- Recent filings focus on novel chemical scaffolds and delivery mechanisms.
- Poland's patent law aligns with European standards, providing a robust environment for pharmaceutical patents.
Patent opposition and litigation
- No publicly available information on opposition or litigation concerning PL2819648 as of the latest status.
- Generally, patents in this field face scrutiny during examination for novelty and inventive step.
Summary of legal and strategic considerations
- The patent appears to provide a robust protection scope within Poland for specific compounds and uses.
- Claims should be scrutinized for overlap with existing patents to assess freedom-to-operate.
- The patent landscape suggests ongoing innovation with incremental improvements common in this therapeutic class.
- Strategic patenting beyond Poland could extend protection, especially within the EU.
Key Takeaways
- Patent PL2819648 protects specific pharmaceutical compounds, uses, or processes with narrowly defined claims tailored for the Polish market.
- The patent landscape shows active innovation, potential overlaps, and ongoing filings in Europe.
- The scope is limited geographically but can influence regional markets if filed in broader jurisdictions.
- Competitors operate within a dense patent space, requiring careful freedom-to-operate analysis.
- The patent's strength depends on claim breadth, prosecution history, and ongoing patent activities in the therapeutic area.
FAQs
-
What types of claims are typically found in pharmaceutical patents like PL2819648?
Core claims cover chemical compounds, formulations, methods of use, and manufacturing processes, with dependent claims narrowing the scope.
-
How does Poland's patent law impact pharmaceutical patent protection?
Poland conforms to European patent standards, allowing patent protection for pharmaceuticals with proper novelty, inventive step, and industrial applicability.
-
Can the patent be extended beyond Poland?
Protection can be extended via European patents or national filings in other jurisdictions, depending on strategy.
-
Are there any known challenges or oppositions to PL2819648?
No publicly available opposition or legal challenges are recorded to date.
-
What should companies consider regarding patent landscape when developing similar drugs?
They must analyze overlapping patents, consider filing new applications for incremental innovations, and evaluate freedom-to-operate.
References
[1] European Patent Office. "European Patent Classification (ECLA)." Accessed 2023.
[2] Polish Patent Office. "Patent Law and Regulations." 2023.
[3] World Intellectual Property Organization. "Patent Landscape Reports." 2023.
